Literature DB >> 3749444

Cyclophosphamide induces more chromosome damage than chlorambucil in patients with connective tissue diseases.

R G Palmer, C J Dore, A M Denman.   

Abstract

The potential for damaging chromosomes of the powerful and widely-used immunosuppressive agent cyclophosphamide has been tested by measuring sister chromatid exchanges in blood lymphocytes of patients with connective tissue diseases. This agent induces more chromosome damage than chlorambucil emphasising the need for sensitive means of predicting patients at particular risk of drug-induced malignant disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3749444

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  5 in total

1.  High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's disease.

Authors:  H H Tessler; T Jennings
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

2.  Wegener's granulomatosis.

Authors:  K E Sack
Journal:  West J Med       Date:  1989-03

Review 3.  Therapy of idiopathic membranous nephropathy.

Authors:  C Ponticelli; P Zucchelli; P Passerini
Journal:  Springer Semin Immunopathol       Date:  1987

4.  Chromosomal changes in rheumatoid arthritis patients treated with CPH82.

Authors:  S Rantapää Dahlqvist; I Nordenson
Journal:  Clin Rheumatol       Date:  1996-11       Impact factor: 2.980

Review 5.  Clinical pharmacology and modification of autoimmunity and inflammation in rheumatoid disease.

Authors:  R Luqmani; C Gordon; P Bacon
Journal:  Drugs       Date:  1994-02       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.